Exton, Pa. – September 18, 2026 -- Kibow Biotech's redesigned website, KibowBiotech.com, has been named Best Science Website in the 2026 WebAward Competition, run by the Web Marketing Association across seven judging criteria including design, innovation, content and ease of use.
Kibow expands Renadyl distribution into Canada as part of global rollout
The company's flagship product, Renadyl®, a clinically studied probiotic dietary supplement built on gut-kidney axis research, is now sold worldwide, with an upcoming expansion into Canada marking the latest step in Kibow's international access strategy.
Kibow prepares Renaphil launch to extend kidney probiotic science to pets
The company is developing RenaphilTM, a kidney probiotic formulated specifically for cats and dogs, applying nearly 30 years of gut-kidney research to companion-animal health.
PRISM Marketing built the award-winning site to translate clinical research into public-facing content
KibowBiotech.com was developed in collaboration with PRISM Marketing and consolidates Kibow's clinical trial data, scientific posters, peer-reviewed publications and product portfolio information on chronic kidney disease and the gut microbiome.
Mike Kane, President of Kibow Biotech, said the website gives the company a channel to share kidney health science and credible information with a broader audience.
Kibow, founded in 1997, was also named the American Association of Naturopathic Physicians' 2026 Corporation of the Year.